Tag: Covid-19
-
Student Lab Wins Covid-19 Mask Challenge
An interdisciplinary university student lab won top prize in a design competition for a new type of face mask to block Covid-19 transmissions.
-
Global Vaccine Funds in Covid-19 Relief Bill
The Covid-19 relief bill that the U.S. Congress expects to pass today has more funds for an international group distributing vaccines to low-resource regions.
-
Infographic – Vaccine Support Grows Across Ethnic Lines
A survey this month shows growing acceptance of Covid-19 vaccines across racial and ethnic lines, with Black Americans somewhat less willing than White or Hispanic Americans.
-
Univ. Lab, Biotech Partner on Covid-19 Vaccine Implant
A biotechnology company and university infectious disease lab are developing a Covid-19 vaccine given as a solid dose implant under the skin.
-
Large Trial Testing Covid-19 Antibody Therapies
A clinical trial conducted by National Institutes of Health is evaluating two more synthetic antibodies as treatments for patients hospitalized with Covid-19 infections.
-
Fitness, Phone Data Captured for Heart Health Project
A digital health company is partnering with a cardiologist group to capture data from smartphones and wearable devices to provide users personalized heart health information.
-
Gates Funding Home-Based Crispr Covid-19 Diagnostic
A medical device developer is receiving a Gates Foundation grant for a simple test to detect Covid-19 infections, done completely at home.
-
AbbVie Acquires Coronavirus Antibody Therapy
Drug maker AbbVie is licensing a synthetic antibody to treat Covid-19 and SARS coronaviruses that the company began funding in June.
-
Infographic – Rich Nations Buy Most Covid-19 Vaccines
U.S., European Union, and five other countries, representing 14 percent of the world’s population, already bought up 53 percent of initial supplies of Covid-19 vaccine doses.
-
Covid-19 Antibody Developer Raises $483M in IPO
A biotechnology company developing therapeutic antibodies for Covid-19 infections is raising $483 million in its initial public offering of common stock.